These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30808235)

  • 1. Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.
    Guilbaud M; Devaux M; Couzinié C; Le Duff J; Toromanoff A; Vandamme C; Jaulin N; Gernoux G; Larcher T; Moullier P; Le Guiner C; Adjali O
    Hum Gene Ther; 2019 Jul; 30(7):802-813. PubMed ID: 30808235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.
    Favre D; Blouin V; Provost N; Spisek R; Porrot F; Bohl D; Marmé F; Chérel Y; Salvetti A; Hurtrel B; Heard JM; Rivière Y; Moullier P
    J Virol; 2002 Nov; 76(22):11605-11. PubMed ID: 12388721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates.
    Le Guiner C; Stieger K; Toromanoff A; Guilbaud M; Mendes-Madeira A; Devaux M; Guigand L; Cherel Y; Moullier P; Rolling F; Adjali O
    PLoS One; 2014; 9(9):e102538. PubMed ID: 25248159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle.
    Léger A; Le Guiner C; Nickerson ML; McGee Im K; Ferry N; Moullier P; Snyder RO; Penaud-Budloo M
    PLoS One; 2011; 6(6):e20881. PubMed ID: 21687632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans.
    Gernoux G; Gruntman AM; Blackwood M; Zieger M; Flotte TR; Mueller C
    Mol Ther; 2020 Mar; 28(3):747-757. PubMed ID: 31982038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Utero Transfer of Adeno-Associated Viral Vectors Produces Long-Term Factor IX Levels in a Cynomolgus Macaque Model.
    Mattar CNZ; Gil-Farina I; Rosales C; Johana N; Tan YYW; McIntosh J; Kaeppel C; Waddington SN; Biswas A; Choolani M; Schmidt M; Nathwani AC; Chan JKY
    Mol Ther; 2017 Aug; 25(8):1843-1853. PubMed ID: 28462816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.
    Stieger K; Le Meur G; Lasne F; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Martin L; Moullier P; Rolling F
    Mol Ther; 2006 May; 13(5):967-75. PubMed ID: 16442848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postsurgical assessment and long-term safety of recombinant adeno-associated virus-mediated gene transfer into the retinas of dogs and primates.
    Le Meur G; Weber M; Péréon Y; Mendes-Madeira A; Nivard D; Deschamps JY; Moullier P; Rolling F
    Arch Ophthalmol; 2005 Apr; 123(4):500-6. PubMed ID: 15824224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of immunotoxicity after regional intravenous (RI) delivery of rAAV to nonhuman primate skeletal muscle.
    Toromanoff A; Adjali O; Larcher T; Hill M; Guigand L; Chenuaud P; Deschamps JY; Gauthier O; Blancho G; Vanhove B; Rolling F; Chérel Y; Moullier P; Anegon I; Le Guiner C
    Mol Ther; 2010 Jan; 18(1):151-60. PubMed ID: 19888197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.
    Penaud-Budloo M; Le Guiner C; Nowrouzi A; Toromanoff A; Chérel Y; Chenuaud P; Schmidt M; von Kalle C; Rolling F; Moullier P; Snyder RO
    J Virol; 2008 Aug; 82(16):7875-85. PubMed ID: 18524821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle.
    Chenuaud P; Larcher T; Rabinowitz JE; Provost N; Joussemet B; Bujard H; Samulski RJ; Favre D; Moullier P
    Mol Ther; 2004 Mar; 9(3):410-8. PubMed ID: 15006608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early interaction of adeno-associated virus serotype 8 vector with the host immune system following intramuscular delivery results in weak but detectable lymphocyte and dendritic cell transduction.
    Gernoux G; Guilbaud M; Dubreil L; Larcher T; Babarit C; Ledevin M; Jaulin N; Planel P; Moullier P; Adjali O
    Hum Gene Ther; 2015 Jan; 26(1):1-13. PubMed ID: 25333770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.
    Unzu C; Hervás-Stubbs S; Sampedro A; Mauleón I; Mancheño U; Alfaro C; de Salamanca RE; Benito A; Beattie SG; Petry H; Prieto J; Melero I; Fontanellas A
    J Transl Med; 2012 Jun; 10():122. PubMed ID: 22704060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful attenuation of humoral immunity to viral capsid and transgenic protein following AAV-mediated gene transfer with a non-depleting CD4 antibody and cyclosporine.
    McIntosh JH; Cochrane M; Cobbold S; Waldmann H; Nathwani SA; Davidoff AM; Nathwani AC
    Gene Ther; 2012 Jan; 19(1):78-85. PubMed ID: 21716299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle.
    Toromanoff A; Chérel Y; Guilbaud M; Penaud-Budloo M; Snyder RO; Haskins ME; Deschamps JY; Guigand L; Podevin G; Arruda VR; High KA; Stedman HH; Rolling F; Anegon I; Moullier P; Le Guiner C
    Mol Ther; 2008 Jul; 16(7):1291-9. PubMed ID: 18461055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene Transfer.
    Brimble MA; Morton CL; Winston SM; Reeves IL; Spence Y; Cheng PH; Zhou J; Nathwani AC; Thomas PG; Souquette A; Davidoff AM
    Hum Gene Ther; 2024 Jul; 35(13-14):477-489. PubMed ID: 38420654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.
    Han Y; Chang QA; Virag T; West NC; George D; Castro MG; Bohn MC
    Gene Ther; 2010 May; 17(5):616-25. PubMed ID: 20164859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products.
    Yuasa K; Yoshimura M; Urasawa N; Ohshima S; Howell JM; Nakamura A; Hijikata T; Miyagoe-Suzuki Y; Takeda S
    Gene Ther; 2007 Sep; 14(17):1249-60. PubMed ID: 17581597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.